Factor XIIIa Antibody (YA5726)
(Synonyms: Coagulation factor XIII A chain; Coagulation factor XIIIa; Protein-glutamine gamma-glutamyltransferase A chain; Transglutaminase A chain; )Factor XIIIa Antibody (YA5726) is a Mouse-derived and non-conjugated IgG1 monoclonal antibody, targeting to Factor XIIIa.
-
Host:
Mouse
-
Isotype:
IgG
-
Application:
IHC-P, ELISA
-
Reactivity :
Human, Mouse, Rat
-
Formulation:
Supplied in PBS, 50% glycerol, 0.05% Proclin 300, 0.05%BSA
-
Conjugation:
Non-conjugated
To place orders, for customer services and technical support, please contact: MedChemExpress USA
Tel: 609-228-6898 E-mail: [email protected] [email protected]
Applications
| Application |
IHC-P
IHC-P: Immunohistochemistry-Paraffin
|
ELISA
ELISA: Enzyme Linked Immunosorbent Assay
|
|---|---|---|
| Dilution Ratio | 1:200-400 | 1:500-5000 |
Product Details
Factor XIIIa Antibody (YA5726) is a Mouse-derived and non-conjugated IgG1 monoclonal antibody, targeting to Factor XIIIa.
-
Host Mouse
-
Clonality Monoclonal
-
Species ReactivityHuman, Mouse, Rat
-
Observed Molecular WeightObserved band size: 83 kDa
Note: Due to possible protein modifications or aggregation, the molecular weight should be confirmed by actual measurement, and the predicted value is for reference only.
-
Calculated Molecular Weight Predicted band size: 76 kDa,83 kDa
Synthesized peptide derived from human Factor XIIIa AA range: 400-500
affinity chromatography.
Non-conjugated
Unmodified
IgG
Product Properties
-
Appearance
Solution
-
Formulation
Supplied in PBS, 50% glycerol, 0.05% Proclin 300, 0.05%BSA
-
Storage & Stability
Stored at -20°C for 1 year. Avoid repeated freeze / thaw cycles.
-
Shipping
Shipping with blue ice.
Background
-
Function
Factor XIIIA (FXIII-A) is the catalytic subunit of coagulation factor XIII and acts as a transglutaminase that forms ε- (γ-glutamyl) lysyl cross-links in protein substrates[1]. In plasma, FXIII circulates as FXIII-A2B2, where A subunits provide catalytic activity and B subunits act as non-enzymatic carrier subunits[2]. Mechanistically, thrombin and Ca2+ convert plasma FXIII into active FXIIIa, which stabilizes fibrin clots, links α2-antiplasmin to fibrin, and protects clots from fibrinolysis[1][3]. Beyond hemostasis, FXIII-A supports wound healing, tissue repair, pregnancy maintenance, and angiogenesis, making it relevant for coagulation biology and regenerative research[1][2]. In disease models, FXIII deficiency impaired wound healing and aggravated cardiac rupture after myocardial infarction in mice[4]. In inflammatory disease, macrophage-derived FXIII-A linked extravascular coagulation to COPD-associated inflammation, while macrophage-derived foam cells expressed cellular FXIII-A in atherosclerosis-related models[5][6]. Compared with FXIII-B, FXIII-A is the enzymatic isoform and therefore provides the primary experimental target for activity assays, genetic models, and inhibitor studies[2][3]. For experimental applications, tridegin inhibits plasma and platelet FXIIIa, and structure-function studies support its use as a peptide scaffold for FXIIIa inhibitor design[7][8].
-
Subcellular Localization
Cytoplasm; Secreted
-
Subunit
Tetramer of two A chains (F13A1) and two B (F13B) chains
-
SwissProt ID
-
Synonyms
Coagulation factor XIII A chain; Coagulation factor XIIIa; Protein-glutamine gamma-glutamyltransferase A chain; Transglutaminase A chain;
Documentation
References
[1]. Muszbek L, et al. Factor XIII: a coagulation factor with multiple plasmatic and cellular functions. Physiol Rev. 2011 Jul;91(3):931-72. [Content Brief]
[2]. Alshehri FSM, et al. Factor XIII-A: An Indispensable \"Factor\" in Haemostasis and Wound Healing. Int J Mol Sci. 2021 Mar 17;22(6):3055. [Content Brief]
[3]. Komáromi I, et al. Factor XIII: novel structural and functional aspects. J Thromb Haemost. 2011 Jan;9(1):9-20. [Content Brief]
[4]. Nahrendorf M, et al. Factor XIII deficiency causes cardiac rupture, impairs wound healing, and aggravates cardiac remodeling in mice with myocardial infarction. Circulation. 2006 Mar 7;113(9):1196-202. [Content Brief]
[5]. Bazzan E, et al. Macrophages-derived Factor XIII links coagulation to inflammation in COPD. Front Immunol. 2023 Apr 25;14:1131292. [Content Brief]
[6]. Somodi L, et al. Cellular FXIII in Human Macrophage-Derived Foam Cells. Int J Mol Sci. 2023 Mar 2;24(5):4802. [Content Brief]
[7]. Finney S, et al. Tridegin, a new peptidic inhibitor of factor XIIIa, from the blood-sucking leech Haementeria ghilianii. Biochem J. 1997 Jun 15;324 ( Pt 3)(Pt 3):797-805. [Content Brief]
[8]. Böhm M, et al. Novel insights into structure and function of factor XIIIa-inhibitor tridegin. J Med Chem. 2014 Dec 26;57(24):10355-65. [Content Brief]
Powered by Bioz
